These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26102034)

  • 21. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
    Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y
    FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
    Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
    J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in lafora progressive myoclonus epilepsy.
    Delgado-Escueta AV
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):428-33. PubMed ID: 17764634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lafora disease: Current biology and therapeutic approaches.
    Mitra S; Gumusgoz E; Minassian BA
    Rev Neurol (Paris); 2022 Apr; 178(4):315-325. PubMed ID: 34301405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.
    Spuch C; Ortolano S; Navarro C
    Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy.
    Dubey D; Ganesh S
    Hum Mol Genet; 2008 Oct; 17(19):3010-20. PubMed ID: 18617530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lafora disease offers a unique window into neuronal glycogen metabolism.
    Gentry MS; Guinovart JJ; Minassian BA; Roach PJ; Serratosa JM
    J Biol Chem; 2018 May; 293(19):7117-7125. PubMed ID: 29483193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laforin, the most common protein mutated in Lafora disease, regulates autophagy.
    Aguado C; Sarkar S; Korolchuk VI; Criado O; Vernia S; Boya P; Sanz P; de Córdoba SR; Knecht E; Rubinsztein DC
    Hum Mol Genet; 2010 Jul; 19(14):2867-76. PubMed ID: 20453062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease.
    Rai A; Mishra R; Ganesh S
    Hum Mol Genet; 2017 Dec; 26(24):4778-4785. PubMed ID: 28973665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Aguado C; García-Giménez JL; Knecht E; Sanz P; Pallardó FV
    Free Radic Biol Med; 2015 Nov; 88(Pt A):30-41. PubMed ID: 25680286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of serum/glucocorticoid-induced kinase 1 (SGK1) underlies increased glycogen levels, mTOR activation, and autophagy defects in Lafora disease.
    Singh PK; Singh S; Ganesh S
    Mol Biol Cell; 2013 Dec; 24(24):3776-86. PubMed ID: 24131995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
    Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
    EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease.
    Perez-Jimenez E; Viana R; Muñoz-Ballester C; Vendrell-Tornero C; Moll-Diaz R; Garcia-Gimeno MA; Sanz P
    Glia; 2021 May; 69(5):1170-1183. PubMed ID: 33368637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.
    Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
    Singh S; Satishchandra P; Shankar SK; Ganesh S
    Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).
    Worby CA; Gentry MS; Dixon JE
    J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lafora disease - from pathogenesis to treatment strategies.
    Nitschke F; Ahonen SJ; Nitschke S; Mitra S; Minassian BA
    Nat Rev Neurol; 2018 Oct; 14(10):606-617. PubMed ID: 30143794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FoxO3a-mediated autophagy is down-regulated in the laforin deficient mice, an animal model for Lafora progressive myoclonus epilepsy.
    Jain N; Mishra R; Ganesh S
    Biochem Biophys Res Commun; 2016 May; 474(2):321-327. PubMed ID: 27107699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
    Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y
    Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.